“Evidence level for effectiveness of glucagon-like peptide-1 receptor agonists respectively sodium glucose co-transporter-2 inhibitors for mitochondrial diabetes is low”, ijmhs, vol. 10, no. 06, pp. 959–960, Jun. 2020, Accessed: Oct. 23, 2026. [Online]. Available: http://www.innovativejournal.in/index.php/ijmhs/article/view/2988